Return visits allow your provider to review response, side effects, adherence, and whether the care plan should change
Serious side effects of the medication include the following: Allergic or hypersensitivity reaction Severe gastrointestinal issues Changes in mood and behavior Pancreatitis Liver problems Low blood sugar levels (hypoglycemia) Cardiac arrhythmias Suicidal ideation Major depressive disorder No adverse event of hypoglycemia or thyroid cancer was reported in Phase II trials, and 7% of retatrutide participants had skin sensitivity, compared to 1% on placebo, but these cases were not serious
MRC Vitamin Study Research Group
Most protocols dose 2 to 3 times per week to maintain elevated cellular NAD+ over time
The standard AOD 9604 dosage in clinical use is 250500 mcg, administered subcutaneously once every morning on an empty stomach, and cycled in 412-week blocks
It helps in the absorption of folic acid and carbohydrates from food